Dados Gerais do Componente Curricular
| Tipo do Componente Curricular: |
MÓDULO |
| Unidade Responsável: |
PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIAS DA SAÚDE (15.26) |
| Código: |
PPGCSA0013 |
| Nome: |
NEW TRENDS IN HEALTH SCIENCES - APPROACHES IN DRUG DELIVERY |
| Carga Horária Teórica: |
30 h. |
| Carga Horária Prática: |
0 h. |
| Carga Horária de Ead: |
0 h. |
| Carga Horária Total: |
30 h. |
| Pré-Requisitos: |
|
| Co-Requisitos: |
|
| Equivalências: |
|
| Excluir da Avaliação Institucional: |
Não |
| Matriculável On-Line: |
Sim |
| Horário Flexível da Turma: |
Não |
| Horário Flexível do Docente: |
Sim |
| Obrigatoriedade de Nota Final: |
Sim |
| Pode Criar Turma Sem Solicitação: |
Não |
| Necessita de Orientador: |
Não |
| Exige Horário: |
Sim |
| Permite CH Compartilhada: |
Não |
| Quantidade de Avaliações: |
1 |
| Ementa/Descrição: |
Main Topic:“Drug delivery systems, from the bench to the industry” /
Description:The goal of this course is to provide graduate students with the knowledge about new technologies for research in Health Sciences. Specifically, this course will cover the areas of Drug development and medical devices, New biological approaches for in vitro and in vivo studies, Pharmacokinetics and pharmacodynamics, Clinical trials, and New tools on analytical sciences, covering the areas of Pharmaceutical Sciences, and others. /
First, an Introduction about the step by step on the development of drug delivery systems. Then, the state-of-the-art of in-vitroand in-vivoassays for new drug delivery systemswill be presented.Moreover, the analytical aspects for drug development will be discussed, focused on drug stability and drug content, which impacts the therapeutical aspects of a medicine. Finally, regulatory aspects of new medicines and the translation of the drug development from the bench to the industry will conclude the content of this course. /
Course design: The course duration is one semester with a Week Modulus, five days of around 6 hours classes per day. Each day will begin with one lecture following by case studies using recent publications on the topic. The covering of three main areas of drug development will be presented by three different teachers. Students will then be assigned workshop problems to provide them with an active learning application of the concepts and tools. The evaluation will be performed by a continuous process regarding the involvement of each student on the discussion during the case studies.
|
| Referências: |
SAINZ, Vanessa et al. Regulatory aspects on nanomedicines. Biochemical and biophysical research communications, v. 468, n. 3, p. 504-510, 2015. /
Christine Allen, Kinam Park,What do we do next?Volume 302, 28 May 2019, Page 203 /
C. Solans *, P. Izquierdo, J. Nolla, N. Azemar, M.J. Garcia-Celma, Nano-emulsions, Current Opinion in Colloid & Interface Science 10 (2005) 102 – 110
|
|
|
